Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
- 20 Novembre 2024 - 1 mn de lecture
The study will compare the difference between lanreotide Autogel and placebo on progression free survival in patients who have an endocrine tumour in the pancreas or intestines.
20 Novembre 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
20 Novembre 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
20 Novembre 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
20 Novembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
20 Novembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
20 Novembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
20 Novembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
20 Novembre 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
20 Novembre 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
20 Novembre 2024
1 mn de lecture